Bill Text: TX HB1710 | 2019-2020 | 86th Legislature | Introduced

---

Bill Title: Relating to discussing with a patient the risks of certain controlled substance prescriptions.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Engrossed - Dead) 2019-04-16 - Referred to Health & Human Services [HB1710 Detail]

Download: Texas-2019-HB1710-Introduced.html

---

86R11009 JSC-D
By: Ramos H.B. No. 1710

A BILL TO BE ENTITLED
AN ACT
relating to discussing with a patient the risks of certain
controlled substance prescriptions.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 481.0764, Health and Safety Code, is
amended by adding Subsections (f) and (g) to read as follows:
(f) A prescriber, other than a veterinarian, on issuance of
the initial prescription for a Schedule II controlled substance or
an opioid, shall discuss with the patient and, if the patient is a
minor, the patient's parent, conservator, or guardian, or other
person authorized to consent to the minor's medical treatment:
(1) the risk of addiction associated with the drug
prescribed, including any risk of developing a physical or
psychological dependence on the drug;
(2) the risk of overdose associated with the drug
prescribed; and
(3) the danger of taking the drug with
benzodiazepines, alcohol, or other central nervous system
depressants.
(g) A prescriber who discusses the risks of a controlled
substance prescription under Subsection (f) shall note the
discussion in the patient's medical record.
SECTION 2. The change in law made by this Act applies only
to a prescription issued on or after the effective date of this Act.
A prescription issued before the effective date of this Act is
governed by the law in effect on the date the prescription is
issued, and the former law is continued in effect for that purpose.
SECTION 3. This Act takes effect September 1, 2019.